Undisclosed immunology therapeutic
/ Foghorn Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 06, 2026
I&I Novel Oral Small Molecule. Foghorn is advancing a novel oral small molecule in immunology and inflammation (I&I).
(Investing News Network (INN))
- "IND targeted in 2027."
IND • Immunology • Inflammation
1 to 1
Of
1
Go to page
1